Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-31

Clinical Trial Update: Lessening Organ Dysfunction With VITamin C in Septic ARDS [Phase 3]

View source ↗

Summary

Phase 3 trial investigating high-dose vitamin C to reduce organ dysfunction in septic acute respiratory distress syndrome (ARDS).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin C (ascorbic acid)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Septic, Acute Respiratory Distress Syndrome | Phase 3 | Status: UNKNOWN